Both findings suggest a depress headway and/or a higher viva bioavailability of sildenafil citrate in patients with PAH compared to levelheaded volunteers. In a lowlife pre- and postpartum ontogenesis study, the no-observed-adverse-outcome social disease was 30 mg/kg/Day (equivalent to 5-times the RHD on a mg/m2 basis). In that respect are no controlled clinical data on
